MatsukiyoCocokara (3088) Stock Overview
Operates and manages chain stores, drug stores and insurance dispensing pharmacies in Japan. More details
| Snowflake Score | |
|---|---|
| Valuation | 5/6 |
| Future Growth | 1/6 |
| Past Performance | 4/6 |
| Financial Health | 6/6 |
| Dividends | 4/6 |
Rewards
Risk Analysis
No risks detected for 3088 from our risk checks.
3088 Community Fair Values
Create NarrativeSee what others think this stock is worth. Follow their fair value or set your own to get alerts.
MatsukiyoCocokara & Co. Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | JP¥2,792.50 |
| 52 Week High | JP¥3,393.00 |
| 52 Week Low | JP¥2,022.00 |
| Beta | 0.16 |
| 1 Month Change | -3.56% |
| 3 Month Change | -12.63% |
| 1 Year Change | 34.48% |
| 3 Year Change | 56.30% |
| 5 Year Change | 101.87% |
| Change since IPO | 1,023.81% |
Recent News & Updates
MatsukiyoCocokara (TSE:3088) Ticks All The Boxes When It Comes To Earnings Growth
Oct 08
MatsukiyoCocokara & Co.'s (TSE:3088) Intrinsic Value Is Potentially 57% Above Its Share Price
Aug 29MatsukiyoCocokara & Co. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 15Recent updates
MatsukiyoCocokara (TSE:3088) Ticks All The Boxes When It Comes To Earnings Growth
Oct 08MatsukiyoCocokara & Co.'s (TSE:3088) Intrinsic Value Is Potentially 57% Above Its Share Price
Aug 29MatsukiyoCocokara & Co. Earnings Missed Analyst Estimates: Here's What Analysts Are Forecasting Now
Aug 15MatsukiyoCocokara's (TSE:3088) Returns Have Hit A Wall
Jul 23With EPS Growth And More, MatsukiyoCocokara (TSE:3088) Makes An Interesting Case
Jun 22Calculating The Intrinsic Value Of MatsukiyoCocokara & Co. (TSE:3088)
May 26MatsukiyoCocokara & Co.'s (TSE:3088) Shareholders Might Be Looking For Exit
Apr 10Analysts Have Made A Financial Statement On MatsukiyoCocokara & Co.'s (TSE:3088) Third-Quarter Report
Feb 18MatsukiyoCocokara & Co. (TSE:3088) Shares Could Be 26% Below Their Intrinsic Value Estimate
Feb 10Is MatsukiyoCocokara (TSE:3088) A Risky Investment?
Jan 10Subdued Growth No Barrier To MatsukiyoCocokara & Co.'s (TSE:3088) Price
Dec 05An Intrinsic Calculation For MatsukiyoCocokara & Co. (TSE:3088) Suggests It's 22% Undervalued
Nov 11Shareholder Returns
| 3088 | JP Consumer Retailing | JP Market | |
|---|---|---|---|
| 7D | -3.3% | -0.5% | 1.8% |
| 1Y | 34.5% | 24.8% | 24.7% |
Return vs Industry: 3088 exceeded the JP Consumer Retailing industry which returned 24.8% over the past year.
Return vs Market: 3088 exceeded the JP Market which returned 24.7% over the past year.
Price Volatility
| 3088 volatility | |
|---|---|
| 3088 Average Weekly Movement | 3.7% |
| Consumer Retailing Industry Average Movement | 3.0% |
| Market Average Movement | 3.7% |
| 10% most volatile stocks in JP Market | 7.9% |
| 10% least volatile stocks in JP Market | 2.0% |
Stable Share Price: 3088 has not had significant price volatility in the past 3 months compared to the JP market.
Volatility Over Time: 3088's weekly volatility (4%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 1932 | 12,753 | Kiyoo Matsumoto | www.matsukiyococokara.com |
MatsukiyoCocokara & Co. operates and manages chain stores, drug stores and insurance dispensing pharmacies in Japan. The company is involved in the franchise business development and product supply to franchisees. MatsukiyoCocokara & Co. was founded in 1932 and is headquartered in Tokyo, Japan.
MatsukiyoCocokara & Co. Fundamentals Summary
| 3088 fundamental statistics | |
|---|---|
| Market cap | JP¥1.11t |
| Earnings (TTM) | JP¥55.94b |
| Revenue (TTM) | JP¥1.08t |
Is 3088 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 3088 income statement (TTM) | |
|---|---|
| Revenue | JP¥1.08t |
| Cost of Revenue | JP¥698.24b |
| Gross Profit | JP¥377.28b |
| Other Expenses | JP¥321.34b |
| Earnings | JP¥55.94b |
Last Reported Earnings
Jun 30, 2025
Next Earnings Date
Nov 13, 2025
| Earnings per share (EPS) | 140.59 |
| Gross Margin | 35.08% |
| Net Profit Margin | 5.20% |
| Debt/Equity Ratio | 0.2% |
How did 3088 perform over the long term?
See historical performance and comparisonDividends
Does 3088 pay a reliable dividends?
See 3088 dividend history and benchmarks| MatsukiyoCocokara dividend dates | |
|---|---|
| Ex Dividend Date | Sep 29 2025 |
| Dividend Pay Date | Dec 03 2025 |
| Days until Ex dividend | 35 days |
| Days until Dividend pay date | 30 days |
Does 3088 pay a reliable dividends?
See 3088 dividend history and benchmarksCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/11/02 22:06 |
| End of Day Share Price | 2025/10/31 00:00 |
| Earnings | 2025/06/30 |
| Annual Earnings | 2025/03/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
MatsukiyoCocokara & Co. is covered by 20 analysts. 12 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Arashi Nishizawa | BofA Global Research |
| Mitsuru Takayanagi | Citigroup Inc |
| Nigel Muston | CLSA |